Brand-New bioLIVE China in 2019

Leading the Pharmaceutical trends in Asia!

BioPh China will be upgraded to bioLIVE China in 2019, which will focus on bioscience, biotechnology, bioprocessing & manufacturing and new drugs.

The brand-new event will lead the development and innovation of pharmaceutical industry with the specific exhibition area and high-end conferences.

bioLIVE China 2019, together with CPhI China, will build Asia’s premier partnering platform covering the whole pharmaceutical industry chain from small to large molecule.

| SCOPE OF EXHIBITS |

Biological and New Therapies

  • Recombinant Protein
  • Polypeptide
  • Nucleic Acid
  • Vaccines
  • Plasma
  • Antibodies
  • Cell and Gene Therapy
  • Tumor Immunotherapy
  • Stem Cell & iPS

Biotechnology and R&D Services

  • Molecular Biology
  • Cell Biology
  • Proteomics and Metabolomics
  • Biotechnology Service Platform
  • Detection Services
  • Biology Information Services
  • Drug R&D and Manufacturing
  • Clinical Research

Bioprocessing, Manufacturing and Solutions

  • Cell Culture Media
  • Biological Reagents
  • Laboratory Consumables
  • Bioreactors
  • Bioseparation
  • Protein Purification
  • Bioprocessing